These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8094062)

  • 1. Taxol sensitizes human ovarian cancer cells to radiation.
    Steren A; Sevin BU; Perras J; Angioli R; Nguyen H; Guerra L; Koechli O; Averette HE
    Gynecol Oncol; 1993 Feb; 48(2):252-8. PubMed ID: 8094062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxol as a radiation sensitizer: a flow cytometric study.
    Steren A; Sevin BU; Perras J; Ramos R; Angioli R; Nguyen H; Koechli O; Averette HE
    Gynecol Oncol; 1993 Jul; 50(1):89-93. PubMed ID: 8102348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel: a radiation sensitizer of human cervical cancer cells.
    Rodriguez M; Sevin BU; Perras J; Nguyen HN; Pham C; Steren AJ; Koechli OR; Averette HE
    Gynecol Oncol; 1995 May; 57(2):165-9. PubMed ID: 7729728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
    Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
    Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol sensitizes human astrocytoma cells to radiation.
    Tishler RB; Geard CR; Hall EJ; Schiff PB
    Cancer Res; 1992 Jun; 52(12):3495-7. PubMed ID: 1350755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
    Gorodetsky R; Levdansky L; Ringel I; Vexler A
    Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
    Siler DF; Wheeless CR; Dubin NH
    Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy.
    Lokeshwar BL; Ferrell SM; Block NL
    Anticancer Res; 1995; 15(1):93-8. PubMed ID: 7733649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined treatment with radiation and low dose etoposide on cell survival.
    Shigematsu N; Kawata T; Ihara N; Kawaguchi O; Kutsuki S; Ishibashi R; Kubo A; Ito H
    Anticancer Res; 2001; 21(1A):325-8. PubMed ID: 11299757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
    Mason KA; Milas L; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1381-9. PubMed ID: 7635778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol and radiation.
    Geard CR; Jones JM; Schiff PB
    J Natl Cancer Inst Monogr; 1993; (15):89-94. PubMed ID: 7912535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic cytotoxic and antitumor effects of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cells.
    Hornback NB; Shen RN; Sutton GP; Shidnia H; Kaiser HE
    In Vivo; 1994; 8(5):819-23. PubMed ID: 7727730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the ATP-cell viability assay for assessment of in vitro radiation treatment response in gynecologic cancer cell lines.
    Rodriguez M; Steren AJ
    Contrib Gynecol Obstet; 1994; 19():156-65. PubMed ID: 7995047
    [No Abstract]   [Full Text] [Related]  

  • 15. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo.
    Hofstetter B; Vuong V; Broggini-Tenzer A; Bodis S; Ciernik IF; Fabbro D; Wartmann M; Folkers G; Pruschy M
    Clin Cancer Res; 2005 Feb; 11(4):1588-96. PubMed ID: 15746064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines.
    Erlich E; McCall AR; Potkul RK; Walter S; Vaughan A
    Gynecol Oncol; 1996 Feb; 60(2):251-4. PubMed ID: 8631547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
    Cuellar DC; Rhee J; Kyprianou N
    Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer.
    Lee LF; Schuerer-Maly CC; Lofquist AK; van Haaften-Day C; Ting JP; White CM; Martin BK; Haskill JS
    Cancer Res; 1996 Mar; 56(6):1303-8. PubMed ID: 8640818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.